Through this combination, Boston Scientific becomes more diversified, participating in two of the largest medical device markets - interventional cardiology and cardiac rhythm management.
We are excited about combining the talent and experience of Boston Scientific and Guidant employees. We look forward to working with Guidant to complete the transaction quickly and to creating a global leader in cardiovascular devices.
Boston Scientific plans to implement all the recommendations that apply to manufacturers. In particular, we believe an industry-wide, independent committee of outside experts should be established.